Table 33 In vitro cytotoxicity of peptide derivatives
From: A comprehensive review on biological activities of oxazole derivatives
| Compd. | Cytotoxicity (GI50, µM) | ||
|---|---|---|---|
| A-549 lung carcinoma NSCL | HT-29 colon carcinoma | MDA-MB-231 231breast adenocarcinoma | |
| 73 | 0.17 | 0.12 | 0.10 |
| 74 | 0.12 | 0.13 | 0.12 |